African Americans have a lower viral clearance rate with combination interferon and ribavirin therapy for Hepatitis C

被引：0
|
作者：
Hepburn, MJ
Cantu, NS
Hepburn, LM
Kadakia, SC
Lawitz, EJ
机构：
[1] Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA
[2] Johns Hopkins Univ, Baltimore, MD 21218 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
431
引用
收藏
页码：1162 / 1162
页数：1
相关论文
共 50 条
  • [1] African Americans have a lower viral clearance rate with combination interferon and ribavirin therapy for Hepatitis C: Results of two multi-center trials.
    Lawitz, EJ
    Hepburn, M
    Cantu, NS
    Hepburn, LM
    Kadakia, SC
    [J]. HEPATOLOGY, 2001, 34 (04) : 422A - 422A
  • [2] Interferon and Ribavirin combination therapy in chronic hepatitis C: Predictors of sustained viral response
    Osowo, AT
    Jeevanantham, V
    Kothari, T
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S112 - S113
  • [3] Combination therapy for chronic hepatitis C: interferon and ribavirin
    Christie, JML
    Chapman, RWG
    [J]. HOSPITAL MEDICINE, 1999, 60 (05): : 357 - 361
  • [4] Factors of Response to Pegylated Interferon/Ribavirin Combination Therapy and Mechanism of Viral Clearance
    Sugimoto, Kayo
    Kim, Soo Ryang
    El-Shamy, Ahmed
    Imoto, Susumu
    Ando, Kenji
    Kim, Ke Ih
    Tanaka, Yasuhito
    Yano, Yoshihiko
    Kim, Soo Ki
    Hasegawa, Yutaka
    Fujinami, Aya
    Ohta, Mitsuhiro
    Takashi, Hatae
    Hotta, Hak
    Hayashi, Yoshitake
    Kudo, Masatoshi
    [J]. DIGESTIVE DISEASES, 2013, 31 (5-6) : 421 - 425
  • [5] Total clearance of ribavirin (CL/F) is an important factor to improve the combination therapy of interferon and ribavirin for chronic hepatitis C
    Karino, Y
    Toyota, J
    Arakawa, T
    Matsumoto, S
    Kuwata, Y
    Akaike, J
    Yamazaki, K
    Ohmura, T
    Sato, T
    Matsushima, T
    Iino, S
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A719 - A719
  • [6] Interferon-ribavirin combination therapy for chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Chemello, L
    Alberti, A
    Bellobuono, A
    Ideo, G
    Schwartz, R
    Weiland, O
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : S131 - S134
  • [7] Combination of interferon induction therapy and ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Munda-Steindl, P
    Hegenbarth, K
    Gangl, A
    Vogel, W
    [J]. HEPATOLOGY, 2001, 34 (05) : 1006 - 1011
  • [8] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    [J]. HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [9] Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C
    Soza, A
    Hoofnagle, JH
    [J]. HEPATOLOGY, 2003, 38 (01) : 267 - 267
  • [10] Combination therapy with interferon and ribavirin for treatment of patients with chronic Hepatitis C who have failed therapy with interferon alone.
    Lynch, PJ
    Jacobsmeyer, S
    Quigley, M
    Peters, MG
    [J]. HEPATOLOGY, 1998, 28 (04) : 576A - 576A
12345